5th Circ. Judge Skeptical Of Medicare Drug 'Price-Setting'

By Theresa Schliep · May 1, 2024, 5:15 PM EDT

A Fifth Circuit judge on Wednesday sharply criticized the Biden administration's Medicare drug pricing program, characterizing it as government "price-setting" and questioning "what possible procompetitive justification" there can be for penalizing...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Natl Infusion Center v. Becerra

Case Number

Court

Appellate - 5th Circuit

Nature of Suit

2440 Other Civil Rights

Date Filed

March 14, 2024

Recent Articles By Theresa

November 19, 2024
Nonpracticing Doc Can't Testify In Med Mal Case, Court Says
November 15, 2024
Despite Vaccine Spotlight, RFK Jr. A Health Policy 'Unknown'
November 14, 2024
Trump Picks RFK Jr. To Lead Health & Human Services
November 12, 2024
Why The CDC May Look Very Different In Trump's 2nd Term
November 05, 2024
Abortion Ballot Tracker: 7 States Add Protections As Fla. Effort Fails
October 29, 2024
Fla. Health Agency's All-Out Battle Against Abortion Measure
October 24, 2024
'Will Of The People' Upheld With Ohio Abortion Ban Quashed
October 22, 2024
A Tenn. Court Gets Specific On Abortion Ban Exceptions
October 08, 2024
New Research Misconduct Rule May Expose, Chill Witnesses
October 07, 2024
High Court Won't Look At Alabama Frozen Embryo Decision